Role of Bradykinin in Protection of Ischemic Preconditioning in Rabbit Hearts
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Abstract Bradykinin receptor activation has been proposed to be involved in ischemic preconditioning. In the present study, we further investigated the role of this agent in preconditioning in both isolated and in situ rabbit hearts. All hearts were subjected to 30 minutes of regional ischemia followed by reperfusion for 2 hours (in vitro hearts) and 3 hours (in situ hearts). Infarct size was measured by tetrazolium staining and expressed as a percentage of the size of the risk zone. Preconditioning in situ hearts with 5 minutes of ischemia and 10 minutes of reperfusion significantly reduced infarct size to 10.2±2.2% of the risk region (P<.0005 versus control infarct size of 36.7±2.6%). Pretreatment with HOE 140 (26 μg/kg), a bradykinin B 2 receptor blocker, did not alter infarct size in nonpreconditioned hearts (40.6±5.3% infarction) but abolished protection from ischemic preconditioning (34.1±1.6% infarction). However, when HOE 140 was administered during the initial reflow period following 5 minutes of ischemia, protection was no longer abolished (15.6±3.9% infarction versus 13.3±3.8% without HOE 140,P=NS). Bradykinin infusion in isolated hearts mimicked preconditioning, and protection was not affected by pretreatment with the nitric oxide synthase inhibitor Nω-nitro-l-arginine methyl ester or the prostaglandin synthesis inhibitor indomethacin but could be completely abolished by the protein kinase C (PKC) inhibitors polymyxin B and staurosporine as well as by HOE 140. HOE 140 could not block the protection of ischemic preconditioning in isolated hearts. That failure was apparently due to the absence of blood-borne kininogens rather than autonomic nerves. When the preconditioning stimulus in the in situ model was amplified with four cycles of 5-minute ischemia/10-minute reperfusion, HOE 140 pretreatment could no longer block protection (infarct size was 10.7±3.5% versus 6.4±2.0% without HOE 140,P=NS). We propose that bradykinin receptors protect by coupling to PKC as do adenosine receptors, and blockade of either receptor will diminish the total stimulus of PKC below threshold and prevent protection. A more intense preconditioning ischemic stimulus can overcome bradykinin receptor blockade, however, by simply enhancing the amount of adenosine and possibly other agonists released.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo
Rees, D. D., Palmer, R. M. J., Schulz, R., Hodson, H. F., & Moncada, S. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb14151.x · Cited by 1,856
Liu, G. S., Thornton, J., Van Winkle, D. M., Stanley, A. W., Olsson, R. A., & Downey, J. M. (1991) · Circulation · doi:10.1161/01.cir.84.1.350 · Cited by 1,351
Self-citationBlockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.
Gross, G. J., & Auchampach, J. A. (1992) · Circulation Research · doi:10.1161/01.res.70.2.223 · Cited by 949
Preconditioning protects ischemic rabbit heart by protein kinase C activation
Ytrehus, K., Liu, Y., & Downey, J. M. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.3.h1145 · Cited by 615
Self-citationEffects of Anti-inflammatory Drugs on Prostaglandin Biosynthesis
FLOWER, R., GRYGLEWSKI, R., HERBACZŃSKA-CEDRO, K., & VANE, J. R. (1972) · Nature New Biology · doi:10.1038/newbio238104a0 · Cited by 475
Thornton, J. D., Liu, G. S., Olsson, R. A., & Downey, J. M. (1992) · Circulation · doi:10.1161/01.cir.85.2.659 · Cited by 451
Self-citationProtein kinase C. Its role in ischemic preconditioning in the rat.
Speechly-Dick, M. E., Mocanu, M. M., & Yellon, D. M. (1994) · Circulation Research · doi:10.1161/01.res.75.3.586 · Cited by 359
Liu, Y., Ytrehus, K., & Downey, J. M. (1994) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1994.1078 · Cited by 312
Self-citationTsuchida, A., Liu, Y., Liu, G. S., Cohen, M. V., & Downey, J. M. (1994) · Circulation Research · doi:10.1161/01.res.75.3.576 · Cited by 261
Self-citationRole of bradykinin in myocardial preconditioning.
Wall, T. M., Sheehy, R., & Hartman, J. C. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22425-9 · Cited by 244
Cited by
Myocardial ischaemia–reperfusion injury and cardioprotection in perspective
Heusch, G. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0403-y · Cited by 1,234
Preconditioning the myocardium: from cellular physiology to clinical cardiology
YELLON, D. M., & DOWNEY, J. M. (2003) · Physiological Reviews · doi:10.1152/physrev.00009.2003 · Cited by 1,062
Self-citationLeeb-Lundberg, L. M. F., Marceau, F., Müller-Esterl, W., Pettibone, D. J., & Zuraw, B. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.2 · Cited by 943
Heusch, G. (2015) · Circulation Research · doi:10.1161/circresaha.116.305348 · Cited by 811
Tumor necrosis factor in the heart
Meldrum, D. R. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.3.r577 · Cited by 746
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
Zhang, M., Liu, Q., Meng, H., Duan, H., Liu, X., Wu, J., Gao, F., Wang, S., Tan, R., & Yuan, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01688-x · Cited by 712
Consequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 1
Kloner, R. A., & Jennings, R. B. (2001) · Circulation · doi:10.1161/hc4801.100038 · Cited by 634
Bogoyevitch, M. A., Gillespie-Brown, J., Ketterman, A. J., Fuller, S. J., Ben-Levy, R., Ashworth, A., Marshall, C. J., & Sugden, P. H. (1996) · Circulation Research · doi:10.1161/01.res.79.2.162 · Cited by 525
Ping, P., Zhang, J., Qiu, Y., Tang, X.-L., Manchikalapudi, S., Cao, X., & Bolli, R. (1997) · Circulation Research · doi:10.1161/01.res.81.3.404 · Cited by 482
Ischemic Preconditioning: From Adenosine Receptor to KATP Channel
Cohen, M. V., Baines, C. P., & Downey, J. M. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.79 · Cited by 475
Self-citationSurvival kinases in ischemic preconditioning and postconditioning
HAUSENLOY, D., & YELLON, D. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.017 · Cited by 472
Medical and Cellular Implications of Stunning, Hibernation, and Preconditioning: An NHLBI Workshop
Kloner, R. A., Bolli, R., Marban, E., Reinlib, L., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.97.18.1848 · Cited by 440
Kurrelmeyer, K. M., Michael, L. H., Baumgarten, G., Taffet, G. E., Peschon, J. J., Sivasubramanian, N., Entman, M. L., & Mann, D. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070036297 · Cited by 440
Ferdinandy, P., & Schulz, R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705080 · Cited by 439
Loukogeorgakis, S. P., Panagiotidou, A. T., Broadhead, M. W., Donald, A., Deanfield, J. E., & MacAllister, R. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.044 · Cited by 434
ATP-Sensitive Potassium Channels: A Review of their Cardioprotective Pharmacology
Grover, G. J., & Garlid, K. D. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1111 · Cited by 396
Sanada, S., Komuro, I., & Kitakaze, M. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00553.2011 · Cited by 381
Garlid, K. D., Dos Santos, P., Xie, Z.-J., Costa, A. D. T., & Paucek, P. (2003) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(03)00109-9 · Cited by 332
Signal transduction of ischemic preconditioning
Schulz, R. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00384-4 · Cited by 327
Signaling pathways in ischemic preconditioning
Downey, J. M., Davis, A. M., & Cohen, M. V. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9025-2 · Cited by 319
Self-citationVolatile Anesthetics Protect the Ischemic Rabbit Myocardium from Infarction
Cope, D. K., Impastato, K. W., Cohen, M. V., & Downey, J. M. (1997) · Anesthesiology · doi:10.1097/00000542-199703000-00023 · Cited by 319
Self-citationStress-Activated Cytokines and The Heart: From Adaptation to Maladaptation
Mann, D. L. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142249 · Cited by 297
Kerendi, F., Kin, H., Halkos, M. E., Jiang, R., Zatta, A. J., Zhao, Z. –., Guyton, R. A., & Vinten–Johansen, J. (2005) · Basic Research in Cardiology · doi:10.1007/s00395-005-0539-2 · Cited by 292
Preconditioning and postconditioning: United at reperfusion
Hausenloy, D. J., & Yellon, D. M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.005 · Cited by 285
Postconditioning: Reduction of reperfusion-induced injury
ZHAO, Z., & VINTENJOHANSEN, J. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.024 · Cited by 272
Oldenburg, O., Qin, Q., Krieg, T., Yang, X.-M., Philipp, S., Critz, S. D., Cohen, M. V., & Downey, J. M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00360.2003 · Cited by 264
Self-citationPing, P., Takano, H., Zhang, J., Tang, X.-L., Qiu, Y., Li, R. C. X., Banerjee, S., Dawn, B., Balafonova, Z., & Bolli, R. (1999) · Circulation Research · doi:10.1161/01.res.84.5.587 · Cited by 257
Ischaemic preconditioning: present position and future directions
Yellon, D. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00214-9 · Cited by 257
HANLEY, P., & DAUT, J. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.04.002 · Cited by 218
“[50] Goto M, LiuY,Yang XM, Ardell JL, Cohen MV, Downey JM.”
Nakano, A., Liu, G. S., Heusch, G., Downey, J. M., & Cohen, M. V. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1152 · Cited by 171
Self-citationThe kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins
Blais, C., Marceau, F., Rouleau, J.-L., & Adam, A. (2000) · Peptides · doi:10.1016/s0196-9781(00)00348-x · Cited by 135
Mitochondrial KATP channels in preconditioning
Oldenburg, O. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00115-9 · Cited by 94
Transgenic overexpression of cardiac A1adenosine receptors mimics ischemic preconditioning
Morrison, R. R., Jones, R., Byford, A. M., Stell, A. R., Peart, J., Headrick, J. P., & Matherne, G. P. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.3.h1071 · Cited by 44
Treatment of Oxidative Stress with Exosomes in Myocardial Ischemia
Liu, Y., Wang, M., Liang, Y., Wang, C., Naruse, K., & Takahashi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041729 · Cited by 42
“Preconditioning can lead to the release of hormones or agonists, such as adenosine [167], opioids [168], and bradykinin [169].”
BackgroundSelf-citation
Metadata
- Authors
- Goto, M., Liu, Y., Yang, X.-M., Ardell, J. L., Cohen, M. V., & Downey, J. M.
- Venue
- Circulation Research
- Published
- 1995-09
- Volume
- 77
- Issue
- 3
- Pages
- 611-621
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W1986905765
- Cited by
- 529
- References
- 43
- FWCI
- 28.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.